Kevin Richard Haas - 28 May 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Technology Officer
Signature
By: Nathan A. Smith For: Kevin Richard Haas
Issuer symbol
MYGN
Transactions as of
28 May 2021
Net transactions value
+$5,456
Form type
4
Filing time
03 Jun 2021, 18:42:10 UTC
Next filing
27 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $5,456 +344 +0.62% $15.86 56,113 28 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).